Mainstreet Equity Corp. Announces Quarterly Dividend Increase by 100% for Period Ending December 31, 2025


This press release contains certain forward-looking statements, including, but not limited to, statements relating to the payment of the dividend, and can generally be identified by the use of words such as “may”, “will”, “could”, “should”, “would”, “likely”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “plan”, “objective” and “continue” and words and expressions of similar import. Although Mainstreet believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. Important factors that could cause actual results to differ materially from expectations include but are not limited to: general business and economic conditions; cost and timing of the development of existing properties; availability of capital to fund property stabilization programs; risks associated with the real estate industry, including labour availability and costs, costs of renovation, fluctuations in vacancy rates, rent control, fluctuations in utility and energy costs, credit risk of tenants, fluctuations in interest rates and availability of capital; changes in laws and regulations; legal and regulatory proceedings; and the ability to execute strategic plans. Mainstreet does not undertake any obligation to update publicly or to revise any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except as required by law.



Source link

  • Related Posts

    China poised for Q1 GDP growth rebound but Iran war dims 2026 outlook: Reuters poll

    By Kevin Yao BEIJING, April 13 (Reuters) – China’s economy likely regained some momentum in the first quarter on solid exports, but growth is expected to cool over the rest…

    Epitopea Strengthens Scientific Advisory Board with Appointment of Leading Authority in Cancer, Lisa Butterfield

    CAMBRIDGE, United Kingdom and MONTREAL, April 13, 2026 (GLOBE NEWSWIRE) — Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies for hard-to-treat solid tumors, today announced the appointment…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    As session returns, Eby's government faces 'peril' over DRIPA: political scientist

    As session returns, Eby's government faces 'peril' over DRIPA: political scientist

    Deep-fried food banned in new plans for school dinners

    Deep-fried food banned in new plans for school dinners

    China poised for Q1 GDP growth rebound but Iran war dims 2026 outlook: Reuters poll

    China poised for Q1 GDP growth rebound but Iran war dims 2026 outlook: Reuters poll

    What the ‘Real Housewives’ Think About Congress’s Reality TV Drama

    Metal Gear Solid movie finds new directors

    Metal Gear Solid movie finds new directors

    Cancer remains top cause of death in Canada as new study shows multiple types rising

    Cancer remains top cause of death in Canada as new study shows multiple types rising